Agilent Technologies, Inc. (NYSE:A) Shares Sold by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 14.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,957 shares of the medical research company’s stock after selling 319 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Agilent Technologies were worth $229,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Redwood Park Advisors LLC bought a new stake in Agilent Technologies in the fourth quarter valued at about $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $29,000. Whipplewood Advisors LLC raised its position in shares of Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 186 shares in the last quarter. Sunbelt Securities Inc. lifted its stake in Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Finally, Opal Wealth Advisors LLC bought a new position in Agilent Technologies during the first quarter worth $31,000.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on A shares. JPMorgan Chase & Co. lowered their target price on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating for the company in a research note on Thursday, May 29th. Robert W. Baird dropped their price objective on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating on the stock in a research note on Thursday, May 22nd. TD Cowen raised their target price on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a report on Thursday, May 29th. UBS Group lowered their target price on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating for the company in a report on Thursday, May 29th. Finally, Wells Fargo & Company dropped their price target on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $140.15.

Agilent Technologies Stock Performance

A opened at $115.61 on Friday. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The stock has a market cap of $32.84 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 3.51 and a beta of 1.23. The business’s 50 day moving average is $110.67 and its 200-day moving average is $124.70. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. Agilent Technologies’s revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.86%. Agilent Technologies’s dividend payout ratio (DPR) is 24.44%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.